ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Tianda Pharmaceuticals Ltd. ?
Unrated Stock - No Analysis Available
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-10.04%
EBIT Growth (5y)
-230.42%
EBIT to Interest (avg)
-10.17
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
0.08
Sales to Capital Employed (avg)
0.60
Tax Ratio
13.02%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0.78%
ROE (avg)
0.33%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.42
EV to EBIT
-3.99
EV to EBITDA
-10.86
EV to Capital Employed
0.47
EV to Sales
0.78
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-11.66%
ROE (Latest)
-13.61%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend5What is working for the Company
NET PROFIT(HY)
Higher at HKD -21.85 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 4.47 times
OPERATING PROFIT(Q)
Highest at HKD -0.22 MM
OPERATING PROFIT MARGIN(Q)
Highest at -0.12 %
-7What is not working for the Company
ROCE(HY)
Lowest at -14.55%
DEBT-EQUITY RATIO
(HY)
Highest at 14.86 %
RAW MATERIAL COST(Y)
Grown by 6.41% (YoY
CASH AND EQV(HY)
Lowest at HKD 64.81 MM
EPS(Q)
Lowest at HKD -0.02
Here's what is working for Tianda Pharmaceuticals Ltd.
Net Profit
Higher at HKD -21.85 MM
than preceding 12 month period ended Dec 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (HKD MM)
Operating Profit
Highest at HKD -0.22 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (HKD MM)
Operating Profit Margin
Highest at -0.12 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Inventory Turnover Ratio
Highest at 4.47 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Depreciation
Highest at HKD 19.77 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (HKD MM)
Here's what is not working for Tianda Pharmaceuticals Ltd.
Debt-Equity Ratio
Highest at 14.86 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
EPS
Lowest at HKD -0.02
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (HKD)
Cash and Eqv
Lowest at HKD 64.81 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Raw Material Cost
Grown by 6.41% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
